Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilcox

Showing results (421-430 of 454) with videos related to

Pageof 46
Sort By:
Stroke|January 2, 2009
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trialHoward N Hodis, Wendy J Mack, Laurie Dustin, et al.
American Heart Journal|June 24, 2010
Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trialR John Simes, Rachel L O'Connell, Philip E Aylward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung diseaseChristoph J Blohmke, Rachel E Victor, Aaron F Hirschfeld, et al.
Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.
Lancet (London, England)|January 29, 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma, Robert A Harrington, David J Moliterno, et al.
The American Journal of Cardiology|December 14, 2002
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living aloneJ Conor O'Shea, Robert G Wilcox, Allan M Skene, et al.
The European Respiratory Journal|March 9, 2019
Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung diseaseAmrit Jhajj, Harinder Pal Gill, Cameron J Hague, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Journal of the American College of Cardiology|February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT InvestigatorsA B Greenbaum, R A Harrington, M P Hudson, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Pageof 46

Showing results (421-430 of 454) with videos related to

Sort By:
Pageof 46
Stroke|January 2, 2009
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trialHoward N Hodis, Wendy J Mack, Laurie Dustin, et al.
American Heart Journal|June 24, 2010
Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trialR John Simes, Rachel L O'Connell, Philip E Aylward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung diseaseChristoph J Blohmke, Rachel E Victor, Aaron F Hirschfeld, et al.
Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.
Lancet (London, England)|January 29, 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma, Robert A Harrington, David J Moliterno, et al.
The American Journal of Cardiology|December 14, 2002
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living aloneJ Conor O'Shea, Robert G Wilcox, Allan M Skene, et al.
The European Respiratory Journal|March 9, 2019
Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung diseaseAmrit Jhajj, Harinder Pal Gill, Cameron J Hague, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Journal of the American College of Cardiology|February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT InvestigatorsA B Greenbaum, R A Harrington, M P Hudson, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
Pageof 46